World's Best Scientists 2026 revealed!
Taisei Mushiroda

Taisei Mushiroda

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Biology and Biochemistry 56 14511 13336 1024 956 188 10346

Taisei Mushiroda publications per year

The chart shows the history of publications by Taisei Mushiroda between 1989 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Taisei Mushiroda published across 38 years, from 1989 to 2026, averaging 7.8 papers a year. Output peaked at 90 publications in 2023. 14 of the 295 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1989 to 2026. Vertical axis: number of publications, 0 to 90. Peak 90 publications in 2023. 1989: 2 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 1 publication 1999: 1 publication 2000: 3 publications 2001: 1 publication 2002: 1 publication 2003: 0 publications 2004: 0 publications 2005: 1 publication 2006: 1 publication 2007: 1 publication 2008: 3 publications 2009: 9 publications 2010: 11 publications 2011: 9 publications 2012: 12 publications 2013: 8 publications 2014: 9 publications 2015: 3 publications 2016: 17 publications 2017: 18 publications 2018: 15 publications 2019: 16 publications 2020: 12 publications 2021: 17 publications 2022: 10 publications 2023: 90 publications 2024: 10 publications 2025: 13 publications 2026: 1 publication
1989 2026

295 publications in total across all disciplines

View publications per year as a table
Taisei Mushiroda: publications per year, 1989 to 2026
Year Publications
1989 2
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 0
1997 0
1998 1
1999 1
2000 3
2001 1
2002 1
2003 0
2004 0
2005 1
2006 1
2007 1
2008 3
2009 9
2010 11
2011 9
2012 12
2013 8
2014 9
2015 3
2016 17
2017 18
2018 15
2019 16
2020 12
2021 17
2022 10
2023 90
2024 10
2025 13
2026 1
Total 295
Download as CSV

Taisei Mushiroda publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Taisei Mushiroda sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 100 bars. Horizontal axis: publications, 47–56 to 1,028+. Vertical axis: number of scientists, 0 to 980. Most scientists, 980, have 127–136 publications. The last bar groups every scientist with 1,028 publications or more. The highlighted bar, 187–196 publications, is where this scientist sits. 47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientist 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientist 1,028+ publications: 100 scientists
47–56 publications 1,028+

This scientist: 188 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

View publications distribution as a table
Number of Biology and Biochemistry scientists by publication count, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
Publications Scientists This scientist
47–56 8
57–66 35
67–76 106
77–86 231
87–96 413
97–106 546
107–116 704
117–126 848
127–136 980
137–146 942
147–156 969
157–166 949
167–176 951
177–186 915
187–196 787 188
197–206 840
207–216 733
217–226 708
227–236 651
237–246 605
247–256 510
257–266 524
267–276 434
277–286 417
287–296 350
297–306 363
307–316 315
317–326 296
327–336 261
337–346 240
347–356 219
357–366 196
367–376 154
377–386 161
387–396 155
397–406 145
407–416 124
417–426 112
427–436 132
437–446 116
447–456 99
457–466 81
467–476 91
477–486 80
487–496 80
497–506 59
507–516 36
517–526 46
527–536 54
537–546 44
547–556 43
557–566 43
567–576 42
577–586 25
587–596 34
597–606 23
607–616 33
617–626 31
627–636 27
637–646 25
647–656 28
657–666 34
667–676 18
677–686 16
687–696 10
697–706 12
707–716 21
717–726 12
727–736 12
737–746 10
747–756 7
757–766 13
767–776 15
777–786 13
787–796 9
797–806 9
807–816 7
817–826 4
827–836 9
837–846 7
847–856 3
857–866 5
867–876 5
877–886 11
887–896 3
897–906 4
907–916 7
917–926 5
927–936 6
937–946 6
947–956 3
957–966 7
967–976 2
977–986 2
987–996 1
997–1,006 5
1,007–1,016 2
1,017–1,026 2
1,027 1
1,028+ 100
Download as CSV

Taisei Mushiroda D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Taisei Mushiroda sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 65 bars. Horizontal axis: D-Index, 40–41 to 167+. Vertical axis: number of scientists, 0 to 1,253. Most scientists, 1,253, have 58–59 D-Index. The last bar groups every scientist with 167 D-Index or more. The highlighted bar, 56–57 D-Index, is where this scientist sits. 40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40–41 D-Index 167+

This scientist: 56 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

View D-Index distribution as a table
Number of Biology and Biochemistry scientists by D-index, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
D-Index Scientists This scientist
40–41 80
42–43 183
44–45 316
46–47 504
48–49 718
50–51 899
52–53 1,025
54–55 1,149
56–57 1,235 56
58–59 1,253
60–61 1,162
62–63 1,130
64–65 1,031
66–67 897
68–69 814
70–71 714
72–73 709
74–75 596
76–77 512
78–79 473
80–81 412
82–83 373
84–85 358
86–87 285
88–89 273
90–91 227
92–93 208
94–95 193
96–97 153
98–99 157
100–101 148
102–103 120
104–105 113
106–107 100
108–109 86
110–111 67
112–113 71
114–115 73
116–117 64
118–119 53
120–121 60
122–123 54
124–125 43
126–127 38
128–129 49
130–131 26
132–133 18
134–135 23
136–137 32
138–139 32
140–141 27
142–143 19
144–145 22
146–147 12
148–149 16
150–151 14
152–153 10
154–155 13
156–157 10
158–159 7
160–161 9
162–163 13
164–165 4
166 4
167+ 98
Download as CSV

Overview

Taisei Mushiroda is affiliated with RIKEN in Japan and has made contributions primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans multiple subfields, notably Pharmacology, Molecular Biology, Genetics, Oncology, and Infectious Diseases.

The scientist's work covers several main topics, including Pharmacogenetics and Drug Metabolism, Drug-Induced Adverse Reactions, Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms, Genetic Associations and Epidemiology, Autoimmune Bullous Skin Diseases, and Blood disorders and treatments.

Taisei Mushiroda has published research in a range of scholarly venues. Frequent publication sites include:

  • Journal of Investigative Dermatology
  • Journal of Human Genetics
  • Clinical Pharmacology & Therapeutics
  • Scientific Reports
  • Blood

Recent papers authored or co-authored by Mushiroda cover diverse topics and publication years, such as:

  • Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy, 2020, Clinical Pharmacology & Therapeutics
  • Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease, 2023, Nature Communications
  • Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm), 2021, Human Genome Variation
  • Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations, 2020, Scientific Reports
  • Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients, 2020, Journal of Investigative Dermatology

Frequent co-authors collaborating with Mushiroda include:

  • Koya Fukunaga
  • Yukihide Momozawa
  • Keiko Hikino
  • Michiaki Kubo
  • Chikashi Terao

Best Publications

  • Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

    Takeshi Ozeki;Taisei Mushiroda;Amara Yowang;Atsushi Takahashi

  • Overview of the BioBank Japan Project: Study design and profile

    Akiko Nagai;Makoto Hirata;Yoichiro Kamatani;Kaori Muto

  • A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis.

    T Mushiroda;S Wattanapokayakit;A Takahashi;T Nukiwa

  • Genetic variants associated with warfarin dose in African- American individuals: a genome-wide association study

    Minoli A Perera;Larisa H Cavallari;Nita A Limdi;Eric R Gamazon

  • Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

    Elizabeth J. Phillips;Chonlaphat Sukasem;Michelle Whirl-Carrillo;Daniel J. Müller

  • Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

    Kazuma Kiyotani;Taisei Mushiroda;Chiyo K. Imamura;Naoya Hosono

  • Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy.

    Kazuma Kiyotani;Taisei Mushiroda;Mitsunori Sasa;Yoshimi Bando

  • A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E

    Manit Nuinoon;Wattanan Makarasara;Taisei Mushiroda;Iswari Setianingsih

  • Genome-wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

    James N. Ingle;Daniel J. Schaid;Paul E. Goss;Mohan Liu

  • HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.

    Soranun Chantarangsu;Taisei Mushiroda;Surakameth Mahasirimongkol;Sasisopin Kiertiburanakul

  • Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

    Taisei Mushiroda;Yozo Ohnishi;Susumu Saito;Atsushi Takahashi

  • Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.

    Kazuma Kiyotani;Taisei Mushiroda;Michiaki Kubo;Hitoshi Zembutsu

  • Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

    Pei Chieng Cha;Taisei Mushiroda;Atsushi Takahashi;Michiaki Kubo

  • Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases.

    Makoto Hirata;Yoichiro Kamatani;Akiko Nagai;Yutaka Kiyohara

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update

    Y. Saito;L.K. Stamp;K.E. Caudle;Hershfield

  • Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis

    Surakameth Mahasirimongkol;Surakameth Mahasirimongkol;Hideki Yanai;Taisei Mushiroda;Watoo Promphittayarat

  • Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population.

    Elitza T. Betcheva;Taisei Mushiroda;Atsushi Takahashi;Michiaki Kubo

  • Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters.

    Kazuma Kiyotani;Taisei Mushiroda;Yusuke Nakamura;Hitoshi Zembutsu

  • A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma.

    Ching Ching Ng;Poh Yin Yew;Suat Moi Puah;Gopala Krishnan

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Human Leukocyte Antigen B (HLA-B) Genotype and Allopurinol Dosing: 2015 update

    Yoshiro Saito;Lisa K. Stamp;Kelly E. Caudle;Michael Hershfield

Frequent Co-Authors

Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Naoyuki Kamatani
Naoyuki Kamatani StaGen (Japan)
Eric R. Gamazon
Eric R. Gamazon Vanderbilt University Medical Center
M. Eileen Dolan
M. Eileen Dolan University of Chicago
Katsushi Tokunaga
Katsushi Tokunaga University of Tokyo
Nancy J. Cox
Nancy J. Cox Vanderbilt University Medical Center
Liewei Wang
Liewei Wang Mayo Clinic
Naoya Hosono
Naoya Hosono University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to a diverse set of careers across the health, research, and administrative sectors. For those eager to expand their qualifications, numerous accredited online programs can pave the way for career advancement or specialization.

Individuals interested in nutrition and public health can explore pursuing an online nutritionist degree. This pathway equips students for roles in community health, wellness clinics, or private consultancy.

Aspiring healthcare managers may look into cahme-accredited online mha programs, preparing graduates for leadership positions within hospitals, clinics, or healthcare systems.

Those already holding nursing credentials can consider the flexibility of an msn to dnp online no clinicals route, enabling them to advance practice and impact healthcare policy without on-site clinical requirements.

For professionals seeking top-tier positions in healthcare leadership, a doctorate in healthcare administration online provides the expertise and credentials to drive organizational change.

Exploring these related online degrees can help students tailor their educational journey to specific career goals within biology, biochemistry, and the broader healthcare field.

Best Scientists Citing Taisei Mushiroda

Trending Scientists

Recently Published Articles